z-logo
open-access-imgOpen Access
Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD
Author(s) -
Rikki M. Tanner,
David A. Calhoun,
Emmy K. Bell,
C. Barrett Bowling,
Orlando M. Gutiérrez,
Marguerite R. Irvin,
Daniel T. Lackland,
Suzanne Oparil,
David G. Warnock,
Paul Muntner
Publication year - 2013
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00550113
Subject(s) - medicine , resistant hypertension , intensive care medicine , cardiology , blood pressure
Apparent treatment-resistant hypertension is defined as systolic/diastolic BP ≥ 140/90 mmHg with concurrent use of three or more antihypertensive medication classes or use of four or more antihypertensive medication classes regardless of BP level.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom